Prostate Cancer Research has announced the creation of a new website for people affected by prostate cancer. Prostate Cancer Research…
What we could do in rare cancer research in 2022 and beyond
'NCRI Consumer lead, Emma Kinloch, shares her thoughts on research into rare cancers on rare disease day 2022. This article…
Introducing Matthew Fok, Chair of the NCRI Early Career Researcher Forum
'Dr Matthew Fok is a general surgical registrar training to be a colorectal surgeon and is Chair of the NCRI…
Patients and carers providing focus for pancreatic cancer research
'On World Pancreatic Cancer Day (18 November), NCRI Consumer Forum member, Lesley Goodburn, wrote about her experiences and how they…
Fewer cases of children’s cancer picked up during COVID pandemic
'A study of cancer in children and young adults in England has found that fewer patients were diagnosed during the…
Simple, cheap urine test can detect urothelial cancers in Lynch Syndrome patients
'Researchers have shown for the first time that it is possible to detect signs of urothelial cancer using a simple,…
Data available for training AI to spot skin cancer are insufficient and lacking in pictures of darker skin
'The images and accompanying data available for training artificial intelligence (AI) to spot skin cancer are insufficient and include very…
Children in the UK and Ireland still diagnosed later with larger kidney cancers than in rest of Europe
'Children with kidney cancers continue to be diagnosed with larger and more advanced tumours in the UK and Ireland than…
New symptoms identified that could help doctors diagnose pancreatic cancer
'Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms – feeling thirsty and…
Patient and public involvement in palliative care research funding decisions
'On World Hospice and Palliative Care Day (9 October) NCRI Consumer Forum member, Paul Charlton, has written about his experiences…
Guidelines for the inclusion of pathology in clinical trial protocols: SPIRIT-Path
'An international group of cancer researchers, led by the National Cancer Research Institute’s (NCRI) Cellular Molecular Pathology Initiative (CMPath), has…
Precision medicine requires next-generation pathology
'New treatments require clinical trials with human participants. The SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) statement1 provides evidence-based…